IMS: US Rx drug sales were flat in 2008

Share this article:
IMS said US prescription drug sales grew 1.3% in 2008 to $291 billion amid increased use of generics, lower sales of new products and slackening consumer demand resulting from the economic downturn.

Dispensed prescription volume grew 0.9% for the year.

By therapeutic category, lipid drugs were the most widely dispensed, followed by codeine and combinations, antidepressants, ACE inhibitors and beta blockers. In terms of sales through retail and non-retail channels, antipsychotics led all therapy classes, followed by lipid drugs, acid reflux drugs and seizure treatments. 
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.